CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- 8-K Event Unregistered share sale
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- NT 10-Q Other NT 10-Q
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-1/A Offering Registration Statement
- 8-K Event Unregistered share sale
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale
- 4 Derivatives Options or other derivatives
Page 5 of 25 · 494 filings